Market Exclusive

Amgen, Inc. (NASDAQ:AMGN) price target raised to $192.00 by Royal Bank of Canada

Analyst Ratings For Amgen, Inc. (NASDAQ:AMGN)

Today, Royal Bank of Canada raised its price target on Amgen, Inc. (NASDAQ:AMGN) to $192.00 per share.

There are 9 Buy Ratings, 8 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Amgen, Inc. (NASDAQ:AMGN) is Buy with a consensus target price of $212.00 per share, a potential 4.35% upside.

Some recent analyst ratings include

Recent Trading Activity for Amgen, Inc. (NASDAQ:AMGN)
Shares of Amgen, Inc. closed the previous trading session at 203.17 −2.83 1.37% with 202.95 shares trading hands.

Exit mobile version